About Highline SCIENCES
Highline SCIENCES is a company based in San Francisco (United States) founded in 2018 was acquired by Tempus in February 2022. Highline SCIENCES offers products and services including CRO Services and Consultancy Services. Highline SCIENCES operates in a competitive market with competitors including Helsinn, Aster Insights, Abogen Biosciences, OnCusp and CancerVax, among others.
- Headquarter San Francisco, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Highline SCIENCES
Highline SCIENCES offers a comprehensive portfolio of products and services, including CRO Services and Consultancy Services.
Full-service contract research for oncology biotech firms and clients.
Bespoke consultancy to address gaps in traditional biotech operations.
People of Highline SCIENCES
Unlock access to complete
Unlock access to complete
Funding Insights of Highline SCIENCES
Detailed funding history for Highline SCIENCES
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Highline SCIENCES
Highline SCIENCES has secured backing from 1 investor. Prominent investors backing the company include Tempus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
AI-based precision medicine solutions for oncology are provided.
|
Locked | Locked | Locked |
Investor details for Highline SCIENCES
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Highline SCIENCES
Investment portfolio details for Highline SCIENCES
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Highline SCIENCES
Detailed financials for Highline SCIENCES
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Highline Sciences Comparisons
Peer comparison for Highline SCIENCES
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Highline SCIENCES
Highline SCIENCES operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helsinn, Aster Insights, Abogen Biosciences, OnCusp and CancerVax, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Oncology therapeutics are developed, manufactured, and commercialized by Helsinn.
|
|
| Locked | Locked | Locked |
Contract-based oncology clinical trial services are provided by Aster Insights.
|
|
| Locked | Locked | Locked |
mRNA-based therapeutics are developed for cancer and infectious diseases.
|
|
| Locked | Locked | Locked |
CRO offering clinical development services for oncology drugs
|
|
| Locked | Locked | Locked |
Cancer vaccine research and development is conducted by CancerVax.
|
|
| Locked | Locked | Locked |
Full-service CRO operations are conducted across more than 20 countries.
|
Detailed competitors of Highline SCIENCES
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Highline Sciences
Complete news archive for Highline SCIENCES
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Highline SCIENCES
Highline SCIENCES was founded in 2018.
Highline SCIENCES is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Highline Sciences was founded in 2018 and is headquartered in San Francisco, United States. As a contract research organization (CRO), focus is placed on clinical development services specifically for oncology drugs. Operations encompass trial design, regulatory support, and data management tailored to pharmaceutical partners in the biotechnology sector. Services are delivered across various phases of drug development, with an emphasis on oncology therapeutics in the North American market.
Highline SCIENCES offers CRO Services and Consultancy Services.
Highline SCIENCES has 1 investor. Key investors include Tempus.